EPISODE · Mar 25, 2018 · 26 MIN
The FDA’s gag rule on off-label treatments
Michael Cannon, director of health policy studies for the Cato Institute, talks about the gag rule that places restrictions on discussing legal uses of drugs for off-label purposes, as well as a bill that would make trial drugs available to terminally ill patients.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What this episode covers
Michael Cannon, director of health policy studies for the Cato Institute, talks about the gag rule that places restrictions on discussing legal uses of drugs for off-label purposes, as well as a bill that would make trial drugs available to terminally ill patients. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
NOW PLAYING
The FDA’s gag rule on off-label treatments
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m